Betashares Global Healthcare Currency Hedged ETF vs VanEck Gold Miners ETF
These ETFs do not share enough listed holdings to estimate overlap.
Scored across Cost (35%), Fund size (20%), Holdings breadth (25%), Income (20%). Past performance is excluded.
See full breakdown ↓Overlap is calculated from each fund's full published holdings list. Where there are no shared listed holdings it is shown as not reliably estimable.
DRUG and GDX are both Thematic ETFs. DRUG tracks the MarketGrader Developed World Healthcare Index and GDX tracks the NYSE Arca Gold Miners Index. DRUG has the lower management fee (0.45% vs 0.53% p.a.). A holdings overlap is not reliably estimable for this pair.
Betashares Global Healthcare Currency Hedged ETF
BetaShares
VanEck Gold Miners ETF
VanEck
Comparison scores reflect how each ETF compares to the other on these specific dimensions only. They are not absolute ratings or recommendations.
Key differences at a glance
Which of DRUG and GDX fits depends on your objectives, not on one being superior. Where the two funds differ most:
Category scores compare these two ETFs only and are not absolute ratings.
DRUG has the lower management fee - the one objective "cheaper" axis.
GDX is the larger fund. Larger is not inherently better, but greater scale can support tighter spreads and lower closure risk.
GDX spreads exposure across more holdings (DRUG 59, GDX 108); the other is more concentrated. Neither is inherently better - it depends on whether you want breadth or a focused tilt.
DRUG distributes approximately 4% and GDX approximately 0.7%; DRUG carries the higher estimated distribution yield. A higher yield may suit an income focus; a lower one may suit a growth or tax-efficiency focus. Yields are estimates and are not guaranteed; past performance is not a reliable indicator of future returns.
Green highlights the factually lower fee or higher scale/income figure. Performance is never highlighted. Data from issuer disclosures, reviewed quarterly.
Yield figures are estimates based on recent distributions and may vary. Past distributions are not a reliable indicator of future distributions.
Past performance is not a reliable indicator of future returns.
Top 10 listed holdings for each fund, from issuer disclosures.
DRUG top holdings
GDX top holdings
Based on each fund's most recently published sector and geographic weightings; figures are approximate. Full breakdowns are shown below.
DRUG sectors
GDX sectors
DRUG geography
GDX geography
Choosing between DRUG and GDX depends on your goals, time horizon and current holdings, not on one being the right answer for everyone. The main differences are summarised above, with the complete data below.
DRUG and GDX do not share enough listed top holdings to reliably estimate a holdings overlap. Compare their fees, holdings and sectors on this page.
DRUG has the lower management fee. DRUG charges 0.45% per year ($45 per year on a $10,000 investment) and GDX charges 0.53% per year ($53 per year on a $10,000 investment). The difference is $8 per year per $10,000 invested.
DRUG (Betashares Global Healthcare Currency Hedged ETF) manages approximately $158M and GDX (VanEck Gold Miners ETF) manages approximately $1.1B. Fund size can affect liquidity and bid-ask spreads but does not by itself change the management fee.
DRUG and GDX do not share enough listed top holdings to estimate overlap, so whether holding both duplicates your exposure depends on their full constituent lists.
There is no universally right choice. It depends on your goals, time horizon and existing holdings. DRUG charges 0.45% and GDX charges 0.53%, so DRUG has the lower management fee. Compare their fees, holdings and sectors above and consider each fund's Product Disclosure Statement and Target Market Determination.
General information only. This comparison and the ETFLens tools on this page provide general information about two exchange-traded funds and do not take into account your personal objectives, financial situation or needs. It is not personal financial product or investment advice. ETFLens does not hold an Australian Financial Services Licence (AFSL). Holdings overlap is calculated from each fund's published holdings (full lists where the issuer publishes one, listed top holdings otherwise), and fee data is sourced from fund manager PDS documents and updated quarterly. Past performance is not a reliable indicator of future returns. Consider each fund's Product Disclosure Statement (PDS) and Target Market Determination (TMD), and seek advice from a registered tax agent or licensed financial adviser, before making investment decisions.
Check your portfolio overlap
See how these ETFs interact with your other holdings.
Open overlap checker →Build your portfolio
ProModel a portfolio with these ETFs and see projected fees and income.
Build a portfolio →View full ETF profiles
Holdings, fees, sectors and distributions for each fund.
DRUG full profile →GDX full profile →Compare another pair
Enter any two ASX ETF tickers to see their side-by-side comparison.
Compare other ETFs →